Trioxifene
From Self-sufficiency
File:Trioxifene.png | |
Systematic (IUPAC) name | |
---|---|
[2-(4-methoxyphenyl)-3,4-dihydronaphthalen-1-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 63619-84-1 |
ATC code | none |
PubChem | CID 50139 |
ChemSpider | 45471 |
Chemical data | |
Formula | C30H31NO3 |
Molar mass | 453.57 g/mol[[Script error: No such module "String".]] |
Trioxifene (LY-133,314) is a selective estrogen receptor modulator (SERM) with competitive binding activity against estradiol for estrogen receptor {alpha} (ER{alpha}) and antagonistic activity against ER{alpha}-mediated gene expression. It has demonstrated anticancer effects in animal studies,[1] indicating that it may be useful for the treatment of breast cancer.
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Naphthalenes
- Pyrrolidines
- Selective estrogen receptor modulators
- Aromatic ketones
- Phenols
- Phenol ethers
- Pharmacology stubs
- 2Fix